Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/64899, first published .
Effect of Adherence to Oral Semaglutide on Glycemic Control in People With Type 2 Diabetes Treated With Metformin: Protocol for an Open-Label Clinical Trial

Effect of Adherence to Oral Semaglutide on Glycemic Control in People With Type 2 Diabetes Treated With Metformin: Protocol for an Open-Label Clinical Trial

Effect of Adherence to Oral Semaglutide on Glycemic Control in People With Type 2 Diabetes Treated With Metformin: Protocol for an Open-Label Clinical Trial

Nynne Sophie Holdt-Caspersen   1, 2 , PhD ;   Claus Dethlefsen   1, 3 , PhD ;   Ole Hejlesen   2 , PhD ;   Erik Christiansen   4 , MD ;   Stine Hangaard   2, 5 , PhD ;   Peter Vestergaard   5, 6, 7 , PhD ;   Morten Hasselstrøm Jensen   1, 2 , PhD

1 Department of Data Science, Novo Nordisk A/S, Aalborg, Denmark

2 Department of Health Science and Technology, Aalborg University, Aalborg, Denmark

3 Department of Mathematical Sciences, Aalborg University, Aalborg, Denmark

4 Department of Medical & Science, Novo Nordisk A/S, Søborg, Denmark

5 Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark

6 Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark

7 Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

Corresponding Author:

  • Nynne Sophie Holdt-Caspersen, PhD
  • Department of Data Science
  • Novo Nordisk A/S
  • Alfred Nobels Vej 27
  • Aalborg 9220
  • Denmark
  • Phone: 45 44448888
  • Email: nynnesh@hst.aau.dk